Related Experiment Video
Updated: May 20, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
Cardiological adverse events after oncological treatment in women
Aneta L Zygulska1, Krzysztof Krzemieniecki
1Oncological Department, University Hospital, Cracow, Poland. zygulska@poczta.onet.pl
Abstract:
Cardiological adverse events after oncological treatment are related to given drugs and patients. Cardiotoxicity is more often observed in the female population. The reason for this phenomenon is unknown. There are no differences in mechanism and duration of cardiotoxicity between men and women. Temporary dysrhythmia, heart failure and cardiomyopathy are the most often adverse effects after oncological treatment. Pathomechanism of cardiomyopathy is related to the presence of free radicals. Prevention against cardiological adverse effects is very important because of the limited options to reverse them. Prevention includes not exceeding the cumulative dose, the anthracycline dose fractionation, adequate qualification for cardiotoxic treatment, liposomal doxorubicins use or dextrasoxane administration to restrict free radicals.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiac Catheterization IV: Nursing Management
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...
Pericarditis IV: Nursing Management
Cardiac Catheterization I: Pre-Procedure Overview
Dysrhythmias VII: Nursing Management of Dysrhythmias

